Henk Stapert, PhD is a serial entrepreneur and an all-round healthcare innovation executive. He is currently CTO of smartQare, a dynamic Dutch start up in the field of remote patient monitoring. Previously he held several senior positions at Philips in program and R&D management, in global innovation portfolio management and innovation strategy. He has 20 years of experience in building new healthcare businesses both via corporate venturing as well as via VC backed startups.
Two of his radical innovations have already grown into successful businesses: The first one is the Idylla molecular diagnostics platform of Biocartis (Euronext, BCART) and the second one is Onvision, an ultrasound guidance and tracking platform, co-branded and marketed by both Philips and B. Braun. The third one, viQtor, a remote patient monitoring solution developed by smartQare, was recently awarded the CE mark under MDR and starts penetrating the markets.
Henk Stapert holds a master degree (1993) in Chemical Technology from the University of Twente and a PhD (1998) in Biomedical Engineering from the same university. After an award winning 2 years fellowship on smart drug delivery systems and photodynamic therapy at the University of Tokyo (1998), he joined Philips in 2000 and has been in several R&D and business positions since then. He has worked in the Netherlands, Belgium, Switzerland and Japan. He is a (co)inventor of over 25 granted patent applications and is a frequently invited speaker.
Henk likes to be in the heart of innovation, creating balanced portfolios and initiating & directing innovative programs that create solutions for the bigger challenges in healthcare, thereby playing an integral role in the company’s innovation portfolio, strategic roadmap and future growth.
In addition, he is a passionate team builder who finds satisfaction in inspiring people to a common, ambitious goal and a team player that takes the lead and responsibility when needed, but finds a lot of satisfaction in coaching team members to empower their career development.